A Single Dose Trial in Healthy Caucasians and Japanese Subjects Investigating the Pharmacokinetics of Somatropin

PHASE1CompletedINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

April 6, 2000

Primary Completion Date

June 8, 2000

Study Completion Date

June 8, 2000

Conditions
Growth Hormone DisorderAdult Growth Hormone DeficiencyHealthy
Interventions
DRUG

somatropin

DRUG

placebo

Trial Locations (1)

96814-4224

Novo Nordisk Investigational Site, Honolulu

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY

NCT00931476 - A Single Dose Trial in Healthy Caucasians and Japanese Subjects Investigating the Pharmacokinetics of Somatropin | Biotech Hunter | Biotech Hunter